Drawing for RESOLUTION PHARMACEUTICALS

USPTO serial 75569159

RESOLUTION PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
KIM, YONG OH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESOLUTION PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JEFFERY L MICHELMAN

JEFFREY L MICHELMAN BLUMENFELD, KAPLAN & SANDWEISS, PC168 N MERAMEC AVESTE 400ST LOUIS, MO 63105

Goods and services

ClassDescriptionStatusFirst use
005Radiopharmaceuticals for clinical or medical laboratory use, namely, radioisotope diagnostic imaging; radiopharmaceuticals and pharmaceutical preparations for the treatment of cancerACTIVE—
042Research and development for others of radiopharmaceuticals, and pharmaceutical preparations and substances, all for use in radioisotope imaging and therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 20, 2002ABN1ABANDONMENT - EXPRESS MAILED—
Mar 26, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2001CNSIINQUIRY AS TO SUSPENSION MAILED—
Apr 14, 2000CNSLLETTER OF SUSPENSION MAILED—
Mar 3, 2000CNEAEXAMINER'S AMENDMENT MAILED—
May 13, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance